SAFETY AND IMMUNOGENICITY OF ONRAB® IN RACCOONS AND SKUNKS IN WEST VIRGINIA – 2011\nFIELD TRIAL REPORT
Notice bibliographique
Résumé
In 2011, a field trial was conducted in southeastern West Virginia to evaluate the safety and immunogenicity of a live recombinant human adenovirus (serotype 5)-rabies glycoprotein vaccine (ONRAB®) in wild raccoons and skunks. ONRAB® was selected for evaluation based on the success achieved in eliminating raccoon rabies from Ontario and Quebec, Canada, through the integration of this vaccine into rabies management strategies and significantly higher sero-positivity in comparison to Raboral V-RG® in studies along the U.S.-Canada border. The field trial site was composed of forested and agricultural habitats in an area where raccoon rabies is enzootic and oral rabies vaccine (ORV) has never been used as a management strategy. The ULTRALITE bait is composed of a small blister pack that contains the ONRAB® vaccine with a waxy coating matrix of sweet attractants, impregnated with tetracycline biomarker, camouflaged by a khaki green dye. Approximately 80,000 baits were distributed at 75 baits/km2 mostly by fixed wing aircraft along parallel flight lines spaced at 750 m intervals. There were no phone calls related to human or pet bait contacts reported through the affixed, legible toll free phone number on each bait. Relatively low human population density in the study area and bait attributes that may make them less attractive to dogs could have been contributing factors resulting in no reported bait contacts. Histopathology results from up to 23 tissue types from diverse target and nontarget wildlife species samples pre (n=290) and post-ORV (n=300) with ONRAB® will be provided under a separate cover once the analysis is completed. No differences were observed between control and treatment captive animals, including cottontail rabbit (Sylvilagus floridanus), opossum (Didelphis virginiana), fox squirrel (Sciurus niger), and eastern wild turkey (Meleagris gallopavo silvestri) that received a 10x ONRAB® dose in a companion histopathology study conducted at the Wildlife Services (WS), National Wildlife Research Center. These species that have not been previously evaluated for potential ONRAB® effects are common to the West Virginia field trial site. The proportion of raccoons categorized as sero-positive was significantly higher in (P< 0.05) the post-ORV ONRAB® baiting period (49.4%, n=296) in comparison to the pre-ORV (9.6%, n=395)) period (naïve to ORV either with ONRAB® or Raboral V-RG® but where raccoon rabies is enzootic). The 49.4% sero-positivity in raccoons was the highest observed by WS for areas with similar management histories that were baited once at 75 baits/km2 with Raboral V-RG®. Biomarker presence was significantly (P<0.05) higher among sero-positive raccoons post-ORV and similar (P>0.05) among raccoons during the pre-ORV period, an indication of vaccine-induced rabies virus neutralizing antibodies (RVNA) following bait consumption. Skunk sample size was inadequate to assess ONRAB® effects, but other studies have not shown a strong RVNA response at 75 baits/km2. Overall, the safety and immunogenicity outcomes from this field trial support replicating the West Virginia field trial to determine if raccoon population immunity would increase as a function of a second annual ORV campaign with ONRAB®. Expansion of field trials into other strategic areas such as the Ohio contingency action zone, the Niagara Frontier and along the Quebec border with New York, Vermont and New Hampshire is recommended.
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction distillée sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.
Scores Codex et Gemma par catégorie
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,005 | 0,001 |
| Méta-épidémiologie (sens strict) | 0,000 | 0,000 |
| Méta-épidémiologie (sens large) | 0,002 | 0,000 |
| Bibliométrie | 0,000 | 0,000 |
| Études des sciences et des technologies | 0,000 | 0,001 |
| Communication savante | 0,000 | 0,000 |
| Science ouverte | 0,000 | 0,000 |
| Intégrité de la recherche | 0,002 | 0,002 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,001 | 0,000 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».